Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

17.60
-0.6200-3.40%
Post-market: 17.770.1700+0.97%19:30 EDT
Volume:2.56M
Turnover:45.28M
Market Cap:1.57B
PE:-7.01
High:18.46
Open:18.46
Low:17.52
Close:18.22
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.69
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:104.09
PE(LYR):-5.34

Loading ...

Syndax says revumenib post-transplant maintenance study shows 90% 2-year survival in acute leukemia patients

Reuters
·
Jun 03

Syndax Pharmaceuticals to host R&D Day spotlighting revumenib, axatilimab programs

Reuters
·
Jun 01

Syndax Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 22

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Syndax Pharmaceuticals (SNDX) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
May 22

Syndax revumenib post-transplant AML maintenance data wins ASCO 2026 oral slot

Reuters
·
May 22

Syndax Announces Four Revuforj® (Revumenib) Abstracts Accepted for Asco 2026, Including an Oral Presentation of Post-Transplant Data

THOMSON REUTERS
·
May 22

AI Hardware Crowded to Extreme Levels While Tech Giants Face Collective Underweighting

Deep News
·
May 20

Syndax CEO Metzger joins TD Cowen Oncology Innovation Summit fireside chat

Reuters
·
May 20

Broadcom's Market Cap Surpasses $2 Trillion for the First Time on May 15th

Deep News
·
May 15

20 Stocks in the S&P 500 of Companies with Soaring Sales and Improving Profit Margins

Dow Jones
·
May 14

Syndax Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
May 13

Syndax price target lowered to $37 from $38 at UBS

TIPRANKS
·
May 13

Syndax Pharmaceuticals (SNDX) Gets a Buy from UBS

TIPRANKS
·
May 13

Memory Price Surge Redefines Industry Dynamics: Upstream Winners See Profits Soar, Downstream Losers Grapple with Costs

Stock News
·
May 13

Top 20 US Stocks by Trading Volume on May 13: Qualcomm Drops Over 11% as Profit-Taking Follows Five-Day Rally

Deep News
·
May 13

Syndax flags revumenib real-world ROAR study interim data ahead of EHA 2026

Reuters
·
May 12

Actuate Therapeutics adds Martin Huber to board of directors

Reuters
·
May 11

$6.2 Billion in 30 Days: How Sandisk, Micron And Seagate Powered One Of The Fastest ETF Launches Ever

Benzinga_recent_news
·
May 11

The Semiconductor Rally Continues to Accelerate

Stock News
·
May 10

Top 20 U.S. Stocks by Trading Volume on May 9: Micron Soars 15.5%, Market Cap Exceeds $800 Billion

Deep News
·
May 09